Intraoperative Margin Re-Resection for Colorectal Liver Metastases

Journal of Surgical Education

Volumn 64, Issue 3, 2007, Pages 150-157

  Wray, Curtis J ^a   Lowy, Andrew M ^a   Matthews, Jeffrey B ^a   James, Laura E ^a   Mammen, Joshua M ^a   Choe, Kyuran A ^a   Hanto, Douglas W ^b   Ahmad, Syed A ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

colorectal cancery; hepatectomy; hepatic neoplasms; Medical Knowledge; metastasis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SIZE; CANCER SURVIVAL; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; INTRAOPERATIVE PERIOD; LABORATORY TEST; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REOPERATION; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURGICAL ANATOMY; SURGICAL TECHNIQUE;

ADULT; AGED; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INTRAOPERATIVE PERIOD; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 34249989462     PISSN: 19317204     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsurg.2007.03.001     Document Type: Article

References (43)

1. Choti M.A., Sitzmann J.V., Tiburi M.F., et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 235 (2002) 759-766
2. de Santibanes E., Lassalle F.B., McCormack L., et al. Simultaneous colorectal and hepatic resections for colorectal cancer: postoperative and longterm outcomes. J Am Coll Surg 195 (2002) 196-202
3. Bozzetti F., Cozzaglio L., Boracchi P., et al. Comparing surgical resection of limited hepatic metastases from colorectal cancer to non-operative treatment. Eur J Surg Oncol 19 (1993) 162-167
4. Fiorentini G., Poddie D.B., De Giorgi U., et al. Global approach to hepatic metastases from colorectal cancer: indication and outcome of intra-arterial chemotherapy and other hepatic-directed treatments. Med Oncol 17 (2000) 163-173
5. Abdalla E.K., Vauthey J.N., Ellis L.M., et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239 (2004) 818-825 discussion 825-827
6. D'Angelica M., Brennan M.F., Fortner J.G., et al. Ninety-six five-year survivors after liver resection for metastatic colorectal cancer. J Am Coll Surg 185 (1997) 554-559
7. Doci R., Gennari L., Bignami P., et al. One hundred patients with hepatic metastases from colorectal cancer treated by resection: analysis of prognostic determinants. Br J Surg 78 (1991) 797-801
8. Bradley A.L., Chapman W.C., Wright J.K., et al. Surgical experience with hepatic colorectal metastasis. Am Surg 65 (1999) 560-566 discussion 566-567
9. Ohlsson B., Stenram U., and Tranberg K.G. Resection of colorectal liver metastases: 25-year experience. World J Surg 22 (1998) 268-276 discussion 276-277
10. Fong Y., Cohen A.M., Fortner J.G., et al. Liver resection for colorectal metastases. J Clin Oncol 15 (1997) 938-946
11. Parikh A.A., Gentner B., Wu T.T., et al. Perioperative complications in patients undergoing major liver resection with or without neoadjuvant chemotherapy. J Gastrointest Surg 7 (2003) 1082-1088
12. Laurent C., Sa Cunha A., Couderc P., et al. Influence of postoperative morbidity on long-term survival following liver resection for colorectal metastases. Br J Surg 90 (2003) 1131-1136
13. Holm A., Bradley E., and Aldrete J.S. Hepatic resection of metastasis from colorectal carcinoma. Morbidity, mortality, and pattern of recurrence. Ann Surg 209 (1989) 428-434
14. Fuhrman G.M., Curley S.A., Hohn D.C., et al. Improved survival after resection of colorectal liver metastases. Ann Surg Oncol 2 (1995) 537-541
15. Elias D., Cavalcanti A., Sabourin J.C., et al. Results of 136 curative hepatectomies with a safety margin of less than 10 mm for colorectal metastases. J Surg Oncol 69 (1998) 88-93
16. Wray C.J., Lowy A.M., Mathews J.B., et al. The significance and clinical factors associated with a subcentimeter resection of colorectal liver metastases. Ann Surg Oncol 12 (2005) 374-380
17. Couinaud C. Liver anatomy: portal (and suprahepatic) or biliary segmentation. Dig Surg 16 (1999) 459-467
18. Scheele J., Stang R., Altendorf-Hofmann A., et al. Resection of colorectal liver metastases. World J Surg 19 1 (1995) 59-71
19. Fong Y., Fortner J., Sun R.L., et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230 (1999) 309-318 discussion 318-321
20. Cady B., Jenkins R.L., Steele Jr. G.D., et al. Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome. Ann Surg 227 (1998) 566-571
21. Smidt M.L., Wegdam J.A., Bremers A.J., et al. Missing evidence for the adequacy of a 1-cm distal margin in resected rectal cancer. Ann Surg Oncol 10 (2003) 823-824
22. Samson P.S., Escovidal L.A., Yrastorza S.G., et al. Re-study of gastric cancer: analysis of outcome. World J Surg 26 (2002) 428-433
23. Blewett C.J., Miller J.D., Ramlawi B., et al. Local recurrence after total or subtotal esophagectomy for esophageal cancer. J Exp Clin Cancer Res 20 1 (2001) 17-19
24. Bozzetti F. Principles of surgical radicality in the treatment of gastric cancer. Surg Oncol Clin N Am 10 (2001) 833-854
25. Bradpiece H.A., Benjamin I.S., Halevy A., and Blumgart L.H. Major hepatic resection for colorectal liver metastases. Br J Surg 74 (1987) 324-326
26. Casson A.G., Darnton S.J., Subramanian S., et al. What is the optimal distal resection margin for esophageal carcinoma?. Ann Thorac Surg 69 1 (2000) 205-209
27. Vauthey J.N., Pawlik T.M., Abdalla E.K., et al. Is extended hepatectomy for hepatobiliary malignancy justified?. Ann Surg 239 (2004) 722-730 discussion 730-732
28. Ekberg H., Tranberg K.G., Andersson R., et al. Determinants of survival in liver resection for colorectal secondaries. Br J Surg 73 (1986) 727-731
29. Gennari L., Doci R., Bignami P., et al. Surgical treatment of hepatic metastases from colorectal cancer. Ann Surg 203 1 (1986) 49-54
30. Wagner J.S., Adson M.A., Van Heerden J.A., et al. The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment. Ann Surg 199 (1984) 502-508
31. Pawlik T.M., Scoggins C.R., Zorzi D., et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 241 (2005) 715-722 discussion 722-724
32. Fazakas J., Mandli T., Ther G., et al. Evaluation of liver function for hepatic resection. Transplant Proc 38 (2006) 798-800
33. Choi H.J., Jung I.K., Kim S.S., et al. Proliferating cell nuclear antigen expression and its relationship to malignancy potential in invasive colorectal carcinomas. Dis Colon Rectum 40 1 (1997) 51-59
34. Zorzi D., Mullen J.T., Abdalla E.K., et al. Comparison between hepatic wedge resection and anatomic resection for colorectal liver metastases. J Gastrointest Surg 10 1 (2006) 86-94
35. DeMatteo R.P., Palese C., Jarnagin W.R., et al. Anatomic segmental hepatic resection is superior to wedge resection as an oncologic operation for colorectal liver metastases. J Gastrointest Surg 4 (2000) 178-184
36. Aloia T.A., Zorzi D., Abdalla E.K., et al. Two-surgeon technique for hepatic parenchymal transection of the noncirrhotic liver using saline-linked cautery and ultrasonic dissection. Ann Surg 242 (2005) 172-177
37. Wray C.J., Rilo H.L., and Ahmad S.A. Colon cancer angiogenesis and antiangiogenic therapy. Expert Opin Investig Drugs 13 (2004) 631-641
38. Fernando N.H., and Hurwitz H.I. Targeted therapy of colorectal cancer: clinical experience with bevacizumab. Oncologist 9 Suppl 1 (2004) 11-18
39. Hurwitz H., Fehrenbacher L., Novotny W., et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350 (2004) 2335-2342
40. Ellis L.M., Curley S.A., and Grothey A. Surgical resection after downsizing of colorectal liver metastasis in the era of bevacizumab. J Clin Oncol 23 (2005) 4853-4855
41. Saif M.W. Targeted agents for adjuvant therapy of colon cancer. Clin Colorectal Cancer 6 1 (2006) 46-51
42. Saad E.D., and Hoff P.M. Chemotherapy of Metastatic Colorectal Cancer. Curr Treat Options Gastroenterol 8 (2005) 239-247
43. Vauthey J.N., Pawlik T.M., Ribero D., et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 24 (2006) 2065-2072